Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disorder with Significantly Decreased T-cell Chimerism Early after Transplantation: A Case Report
Qing-Na Guo,Hai-Sheng Liu,Lin Li,Dian-Ge Jin,Ji-Min Shi,Xiao-Yu Lai,Li-Zhen Liu,Yan-Min Zhao,Jian Yu,Yan-Yuan Li,Fang-Quan Yu,Zhe Gao,Jiao Yan,He Huang,Yi Luo,Yi-Shan Ye
DOI: https://doi.org/10.4329/wjr.v16.i10.600
2024-01-01
World Journal of Radiology
Abstract:BACKGROUND Post-transplant lymphoproliferative disorder (PTLD) is a rare but highly fatal complication occurring after allogeneic hematopoietic cell transplantation (allo-HCT) or solid organ transplantation (SOT). Unlike SOT, PTLD after allo-HCT usually originates from the donor and is rarely accompanied by a loss of donor chimerism. CASE SUMMARY We report a case of Epstein-Barr virus positive PTLD manifesting as diffuse large B-cell lymphoma (DLBCL) with significantly decreased T-cell chimerism early after allo-HCT. A 30-year-old patient with acute myeloid leukemia underwent unrelated allo-HCT after first complete remission. Nearly 3 mo after transplantation, the patient developed cervical lymph node enlargement and gastric lesions, both of which were pathologically suggestive of DLBCL. Meanwhile, the patient experienced a significant and persistent decrease in T-cell chimerism. A partial remission was achieved after chemotherapy with single agent rituximab and subsequent R-CHOP combined chemotherapy. CONCLUSION The loss of T-cell chimerism and the concomitant T-cell insufficiency may be the cause of PTLD in this patient.
What problem does this paper attempt to address?